These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27635198)

  • 1. Mesenchymal stem cells that located in the electromagnetic fields improves rat model of Parkinson's disease.
    Jadidi M; Biat SM; Sameni HR; Safari M; Vafaei AA; Ghahari L
    Iran J Basic Med Sci; 2016 Jul; 19(7):741-8. PubMed ID: 27635198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMF promote BMSCs differentiation and functional recovery in hemiparkinsonian rats.
    Jadidi T; Asadian N; Jadidi M; Ali Vafaei A
    Neurosci Lett; 2022 Jul; 784():136765. PubMed ID: 35777611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats.
    Suzuki S; Kawamata J; Iwahara N; Matsumura A; Hisahara S; Matsushita T; Sasaki M; Honmou O; Shimohama S
    Neurosci Lett; 2015 Jan; 584():276-81. PubMed ID: 25449872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Transplantation of Adipose-Derived Mesenchymal Stem Cells Promoted The Production of Dopaminergic Neurons and Improved Spatial Memory in A Rat Model of Parkinson's Disease.
    Hamedi H; Ghorbanian SH; Mirzaeian L; Abrari K; Mozdziak P; Ghorbanian MT
    Cell J; 2023 May; 25(5):317-326. PubMed ID: 37300293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons.
    Zhao C; Li H; Zhao XJ; Liu ZX; Zhou P; Liu Y; Feng MJ
    Neurochem Res; 2016 Jun; 41(6):1238-49. PubMed ID: 26758268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson's disease rats through neuroprotection and anti-neuroinflammation.
    Jiang Z; Wang J; Sun G; Feng M
    Mol Cell Neurosci; 2022 Dec; 123():103784. PubMed ID: 36228967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactory mucosa stem cells: An available candidate for the treatment of the Parkinson's disease.
    Simorgh S; Alizadeh R; Eftekharzadeh M; Haramshahi SMA; Milan PB; Doshmanziari M; Ramezanpour F; Gholipourmalekabadi M; Seifi M; Moradi F
    J Cell Physiol; 2019 Dec; 234(12):23763-23773. PubMed ID: 31173364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
    Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
    Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
    Hoban DB; Howard L; Dowd E
    Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing neuroprotective effects of CDNF-expressing bone marrow derived mesenchymal stem cells via differing routes of administration utilizing an in vivo model of Parkinson's disease.
    Jiaming M; Niu C
    Neurol Sci; 2015 Feb; 36(2):281-7. PubMed ID: 25159816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ; Batchelor PE; Howells DW
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditioned medium from human amniotic epithelial cells may induce the differentiation of human umbilical cord blood mesenchymal stem cells into dopaminergic neuron-like cells.
    Yang S; Sun HM; Yan JH; Xue H; Wu B; Dong F; Li WS; Ji FQ; Zhou DS
    J Neurosci Res; 2013 Jul; 91(7):978-86. PubMed ID: 23633297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease.
    Levivier M; Przedborski S; Bencsics C; Kang UJ
    J Neurosci; 1995 Dec; 15(12):7810-20. PubMed ID: 8613721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse Embryonic Stem Cells Expressing GDNF Show Enhanced Dopaminergic Differentiation and Promote Behavioral Recovery After Grafting in Parkinsonian Rats.
    Lara-Rodarte R; Cortés D; Soriano K; Carmona F; Rocha L; Estudillo E; López-Ornelas A; Velasco I
    Front Cell Dev Biol; 2021; 9():661656. PubMed ID: 34239871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model.
    Yan M; Sun M; Zhou Y; Wang W; He Z; Tang D; Lu S; Wang X; Li S; Wang W; Li H
    PLoS One; 2013; 8(5):e64000. PubMed ID: 23724014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease.
    Alizadeh R; Kamrava SK; Bagher Z; Farhadi M; Falah M; Moradi F; Boroujeni ME; Soleimani M; Kamyab A; Komeili A
    Neurosci Lett; 2019 Mar; 696():52-59. PubMed ID: 30552942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells and neuroregeneration in Parkinson's disease.
    Glavaski-Joksimovic A; Bohn MC
    Exp Neurol; 2013 Sep; 247():25-38. PubMed ID: 23542820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc (Zn) and adipose-derived mesenchymal stem cells (AD-MSCs) on MPTP-induced Parkinson's disease model: A comparative evaluation of behavioral and immunohistochemical results.
    Yildirim S; Oylumlu E; Ozkan A; Sinen O; Bulbul M; Goksu ET; Ertosun MG; Tanriover G
    Neurotoxicology; 2023 Jul; 97():1-11. PubMed ID: 37146888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.